Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Greece Looks For Savings Of €1.25 Billion On Drug Spending In 2011

This article was originally published in The Pink Sheet Daily

Executive Summary

Electronic prescribing, the promotion of generics and the monitoring of doctors' prescribing are some of the measures to be included to reduce spending on medicines next year.

You may also be interested in...



Roche Suspends Medicines Deliveries To Indebted Greek Hospitals

Mired in economic troubles, Greece's public hospitals owe the drug maker more than €150 million. The health ministry says it is sending cash soon.

Roche Suspends Medicines Deliveries To Indebted Greek Hospitals

Mired in economic troubles, Greece's public hospitals owe the drug maker more than €150 million. The health ministry says it is sending cash soon.

Greece Lowers Drug Prices By Up To 27 Percent

Greece's debt woes lead to cuts in pharmaceutical prices and fears of an increase in parallel trade

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS071658

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel